TAFFIC 30T

Price 3729 INR/ Thousand

Get a Price/Quote

MOQ : 5 Bottles

TAFFIC 30T Specification

Indication
Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS)

Origin of Medicine
Allopathic

Salt Composition
Tamsulosin Hydrochloride 0.4 mg & Tolterodine Tartrate 2 mg

Dosage Form
Tablet (Extended Release)

Pacakaging (Quantity Per Box)
30 Tablets

Drug Type
Prescription Only

Ingredients
Tamsulosin Hydrochloride (Extended Release), Tolterodine Tartrate

Physical Form
Tablets

Function
Urinary retention therapy, relaxes bladder and prostate muscles

Recommended For
Benign Prostatic Hyperplasia (BPH) management

Dosage
As directed by the physician

Dosage Guidelines
One tablet daily or as prescribed

Suitable For
Adults (Male)

Quantity
30 Tablets per pack

Storage Instructions
Store in a cool, dry & dark place. Protect from direct sunlight and moisture.

Prescription Required
Yes

Side Effects
Dizziness, dry mouth, constipation, headache, abnormal ejaculation

Product Type
Pharmaceutical Tablet

Brand Name
TAFFIC 30T

Shelf Life
24 Months

Marketed By
Alkem Laboratories Ltd.

Route of Administration
Oral

Warning & Precaution
Not for use in women, pediatric patients, or those with hypersensitivity to tamsulosin or tolterodine

About TAFFIC 30T

Taffic Tablet contains Bictegravir 50mg, Emtricitabine 200mg and Tenofovir Alafenamide 25mg. This combination is an antiviral medicine combination used in the treatment of Human Immunodeficiency Virus (HIV) 1 infection. Bictegravir is an integrase strand transfer inhibitor. Emtricitabine and Tenofovir Alafenamide is a nucleoside reverse transcriptase inhibitor. It works by reducing the viral load of HIV in your body. This tablet combination improves your immune system and reduces the risk of conditions associated with HIV infection.

Effective BPH Symptom Relief

TAFFIC 30T is specifically designed to address urinary symptoms associated with benign prostatic hyperplasia (BPH) in adult men. Its dual-action formula helps to relax both bladder and prostate muscles, significantly improving urine flow and reducing discomfort. This therapeutic effect makes it a reliable option for those seeking relief from lower urinary tract symptoms.

Convenient Extended Release Formula

The tablet features an extended-release mechanism that ensures a steady release of the active ingredients throughout the day. This allows for once-daily dosing, enhancing adherence to the treatment plan. With each tablet, patients benefit from prolonged therapeutic efficacy and improved symptom management.

Safe Storage and Handling

To maintain the tablet's efficacy, TAFFIC 30T should be stored in a cool, dry, and dark place, protected from direct sunlight and moisture. Each container holds 30 tablets, ensuring a month's supply per pack when following the prescribed daily regimen.

FAQ's of TAFFIC 30T:

Q: How should TAFFIC 30T be taken for optimal efficacy?

A: TAFFIC 30T should be taken orally, once daily, with or without food, as advised by your physician. Consistency in timing each day is recommended to maintain therapeutic levels.

Q: What are the primary benefits of using TAFFIC 30T?

A: The main benefits of TAFFIC 30T include improved urine flow, reduced urgency, and decreased frequency of urination associated with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

Q: Who should avoid using TAFFIC 30T?

A: This medication should not be used by women, children, or individuals with hypersensitivity to tamsulosin or tolterodine. Always consult your physician before starting any new medication.

Q: What side effects may occur with TAFFIC 30T?

A: Possible side effects include dizziness, dry mouth, constipation, headache, and abnormal ejaculation. If you experience severe reactions or allergies, seek medical attention immediately.